BOVIE MEDICAL CORPORATION (NASDAQ:BVX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
Bovie Medical Corporation (the “Company”) recently received notification from Great Point Partners, LLC (“GPP”) that GPP irrevocably waives, among other things, their previously disclosed right to nominate two (2) directors to the Company’s Board of Directors (the “Board”). On December 19, 2016, the Company received notification from Scott Davidson and Charles T. Orsatti, GPP’s nominees to the Board, that they each resign from the Board, effective as of December 19, 2016, and December 31, 2016, respectively. Messrs. Orsatti’s and Davidson’s departures from the Board were not the result of any disagreements with the Company. The Company is actively seeking one (1) or more independent directors to fill the resulting vacancies on the Board.
Item 8.01 Other Events
On December 18, 2016, the Board of Directors unanimously approved the appointment of Michael Geraghty, a member of the Board, to serve as a member and Chairman of the Company’s Compensation Committee, and to serve as a member of the Company’s Audit Committee, each effective upon Mr. Orsatti’s resignation.
About BOVIE MEDICAL CORPORATION (NASDAQ:BVX)